Systemic Antihyperalgesic Effect of a Novel Conotoxin from Californiconus californicus in an Inflammatory Pain Model
23 de enero 2025
Te invitamos a leer el artículo: "Systemic antihyperalgesic effect of a novel conotoxin from Californiconus californicus in an inflammatory pain model", realizado por el Dr. Vinicio Granados Soto, investigador de la Sede Sur del Cinvestav.
Autores: Joaquín López-Carrillo, Johanna Bernáldez-Sarabia, Tushar J. Pawar, Samanta Jiménez, Salvador Dueñas, Andrea Figueroa Montiel, José L. Olivares-Romero, Vinicio Granados Soto, Alexei F. Licea Navarro and Nadia L. Caram Salas.
Abstrac:
Introduction: This study explores the analgesic potential of the novel conotoxin O1_cal6.4b, derived from Californiconus californicus, as a candidate for pain management in a model of inflammatory pain.
Methods: O1_cal6.4b was systemically administered to Wistar rats, and its effects on thermal hyperalgesia and motor coordination were evaluated. Comparative analyses were conducted against O1_cal6.4d, ω-MVIIA, and standard analgesics (morphine, dexamethasone, and diclofenac). Structural differences between O1_cal6.4b and O1_cal6.4d were examined using in silico modeling and molecular dynamics simulations.
Results: Systemic administration of O1_cal6.4b significantly reduced thermal hyperalgesia in a dose-dependent manner without impairing motor coordination. The analgesic effect of O1_cal6.4b was superior to that of O1_cal6.4d, ω-MVIIA, and standard analgesics. Structural analyses revealed notable differences between O1_cal6.4b and O1_cal6.4d, suggesting unique functional properties.
Discussion: The findings indicate that O1_cal6.4b exhibits a promising analgesic profile with advantages over traditional opioid-based therapies. These results underscore the molecular diversity of conotoxins and highlight their potential as innovative analgesic treatments. Further research is needed to elucidate the mechanism of action of this novel conotoxin.
Keywords: conotoxin systemic administration, Californiconus californicus, chronic pain treatments, analgesia, inflammatory pain.